China Uranium Industry: Stock has deviated from its gain value for three consecutive days, cumulatively exceeding 20%, indicating potential risk.

China Uranium Industry announced that the company's stock has experienced abnormal fluctuations, with the closing price deviating by more than 20% for three consecutive trading days. After verification, the company's previous information does not require supplementary corrections, and no major undisclosed information has been found. The company's operations and internal and external environment are normal, and there are no significant undisclosed matters that should be disclosed. The controlling shareholder and the actual controller did not buy or sell the company's stock during the abnormal fluctuations. The company plans to disclose the Annual Report for 2025 in 2026. Investors are reminded to rely on designated media information and invest rationally.